| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 258 | 2019 |
| Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease H Sanjari Moghaddam, F Ghazi Sherbaf, M Mojtahed Zadeh, ... Frontiers in neurology 9, 234, 2018 | 48 | 2018 |
| Longitudinal alterations of alpha-synuclein, amyloid beta, total, and phosphorylated tau in cerebrospinal fluid and correlations between their changes in Parkinson's disease M Dolatshahi, S Pourmirbabaei, A Kamalian, A Ashraf-Ganjouei, M Yaseri, ... Frontiers in neurology 9, 560, 2018 | 45 | 2018 |
| Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective A Javinani, A Ashraf-Ganjouei, S Aslani, A Jamshidi, M Mahmoudi Immunogenetics 71 (4), 283-297, 2019 | 35 | 2019 |
| HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis M Moghoofei, S Mostafaei, A Ashraf-Ganjouei, H Kavosi, M Mahmoudi Microbial pathogenesis 114, 436-443, 2018 | 34 | 2018 |
| Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial M Malek, A Ashraf-Ganjouei, K Moradi, S Bagheri, MR Mohammadi, ... Clinical Neuropharmacology 43 (2), 39-45, 2020 | 28 | 2020 |
| White matter tract alterations in drug-naïve Parkinson’s disease patients with impulse control disorders M Mojtahed Zadeh, A Ashraf-Ganjouei, F Ghazi Sherbaf, M Haghshomar, ... Frontiers in neurology 9, 163, 2018 | 26 | 2018 |
| The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways K Moradi, A Ashraf-Ganjouei, H Tavolinejad, S Bagheri, S Akhondzadeh Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, 110091, 2021 | 25 | 2021 |
| The association between systemic inflammation and cognitive performance in healthy adults A Ashraf-Ganjouei, K Moradi, S Bagheri, MH Aarabi Journal of Neuroimmunology 345, 577272, 2020 | 25 | 2020 |
| Cerebrospinal fluid C-reactive protein in Parkinson’s disease: associations with motor and non-motor symptoms H Sanjari Moghaddam, Z Valitabar, A Ashraf-Ganjouei, ... NeuroMolecular Medicine 20 (3), 376-385, 2018 | 25 | 2018 |
| IL‐1A rs1800587, IL‐1B rs1143634 and IL‐1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis S Abtahi, A Farazmand, M Mahmoudi, A Ashraf‐Ganjouei, A Javinani, ... International journal of immunogenetics 42 (6), 423-427, 2015 | 25 | 2015 |
| Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial A Samaei, K Moradi, S Bagheri, A Ashraf-Ganjouei, R Alikhani, ... International Journal of Neuropsychopharmacology 23 (12), 775-782, 2020 | 23 | 2020 |
| Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double‐blind, placebo … F Ghazizadeh‐Hashemi, S Bagheri, A Ashraf‐Ganjouei, K Moradi, ... Psychiatry and Clinical Neurosciences 75 (8), 250-255, 2021 | 20 | 2021 |
| The relationship between cognitive function and body mass index in multiple sclerosis patients M Owji, A Ashraf-Ganjouei, MA Sahraian, M Bidadian, F Ghadiri, ... Multiple sclerosis and related disorders 32, 37-40, 2019 | 20 | 2019 |
| Serum insulin-like growth factor-1 in Parkinson's disease; study of cerebrospinal fluid biomarkers and white matter microstructure F Ghazi Sherbaf, B Mohajer, A Ashraf-Ganjouei, M Mojtahed Zadeh, ... Frontiers in endocrinology 9, 608, 2018 | 18 | 2018 |
| Microstructural changes in patients with Parkinson's disease comorbid with REM sleep behaviour disorder and depressive symptoms F Ghazi Sherbaf, Y Rostam Abadi, M Mojtahed Zadeh, A Ashraf-Ganjouei, ... Frontiers in neurology 9, 441, 2018 | 18 | 2018 |
| Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an … K Moradi, M Golbakhsh, F Haghighi, K Afshari, R Nikbakhsh, ... International Immunopharmacology 86, 106743, 2020 | 16 | 2020 |
| Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease A Ashraf-Ganjouei, A Majd, A Javinani, MH Aarabi PeerJ 6, e5539, 2018 | 16 | 2018 |
| Altered white matter microstructure associated with mild and moderate depressive symptoms in young adults, a diffusion tensor imaging study F Ghazi Sherbaf, K Same, A Ashraf-Ganjouei, MH Aarabi NeuroReport 29 (8), 685-689, 2018 | 15 | 2018 |
| Magnetic resonance imaging evaluation in patients with linear morphea treated with methotrexate and high-dose corticosteroid M Shahidi-Dadras, F Abdollahimajd, R Jahangard, A Javinani, ... Dermatology research and practice 2018, 2018 | 15 | 2018 |
